“Experimental Approaches to the Assessment of Potential Cardioprotective Means with Doxorubicin-Associated Cardiomyopathy” (2019) Asian Journal of Pharmaceutics (AJP), 12(04). doi:10.22377/ajp.v12i04.2943.